Metastatic Castration-Resistant Prostate Cancer Previously Treated With Docetaxel-Based Chemotherapy: Treatment Patterns From the PROXIMA Prospective Registry

Akaza, Hideyuki; Procopio, Giuseppe; Pripatnanont, Choosak; Facchini, Gaetano; Fava, Sergio; Wheatley, Duncan; Leung, Kwong; Butt, Mohammad; Silva, Alberto; Castillo, Liliana; Karavasilis, Vasilios; Ozatilgan, Ayse; Hitler, Simon; Ecstein-Fraisse, Evelyne; Ozguroglut, MUSTAFA

doi:10.1200/jgo.18.00009

Metastatic Castration-Resistant Prostate Cancer Previously Treated With Docetaxel-Based Chemotherapy: Treatment Patterns From the PROXIMA Prospective Registry

Akaza H., Procopio G., Pripatnanont C., Facchini G., Fava S., Wheatley D., ...More

JOURNAL OF GLOBAL ONCOLOGY, vol.4, 2018 (ESCI, Scopus)

Publication Type: Article / Article
Volume: 4
Publication Date: 2018
Doi Number: 10.1200/jgo.18.00009
Journal Name: JOURNAL OF GLOBAL ONCOLOGY
Journal Indexes: Emerging Sources Citation Index (ESCI), Scopus
Open Archive Collection: AVESIS Open Access Collection
Istanbul University-Cerrahpasa Affiliated: No

Abstract

Purpose There is a major clinical need to devise an optimal treatment sequence for the multiple therapy options available for patients with metastatic castration-resistant prostate cancer (mCRPC). In the absence of prospective clinical trials, sequencing information can be derived from large, real-world registry studies.